Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals is focused on the acute treatment of central nervous system conditions. Alexa’s lead program, ADASUVE, New Drug Application has a PDUFA goal date of December 21, 2012.
Going forward ... (see research report)
Subscribe to News Feeds